BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25184278)

  • 1. Monitoring pancreatic carcinogenesis by the molecular imaging of cathepsin E in vivo using confocal laser endomicroscopy.
    Li H; Li Y; Cui L; Wang B; Cui W; Li M; Cheng Y
    PLoS One; 2014; 9(9):e106566. PubMed ID: 25184278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.
    Cruz-Monserrate Z; Abd-Elgaliel WR; Grote T; Deng D; Ji B; Arumugam T; Wang H; Tung CH; Logsdon CD
    Gut; 2012 Sep; 61(9):1315-22. PubMed ID: 22068166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.
    Pontious C; Kaul S; Hong M; Hart PA; Krishna SG; Lara LF; Conwell DL; Cruz-Monserrate Z
    Pancreatology; 2019 Oct; 19(7):951-956. PubMed ID: 31582345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging.
    Eser S; Messer M; Eser P; von Werder A; Seidler B; Bajbouj M; Vogelmann R; Meining A; von Burstin J; Algül H; Pagel P; Schnieke AE; Esposito I; Schmid RM; Schneider G; Saur D
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9945-50. PubMed ID: 21628592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis.
    Ikezawa K; Hikita H; Shigekawa M; Iwahashi K; Eguchi H; Sakamori R; Tatsumi T; Takehara T
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):185-200.e1. PubMed ID: 28948203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.
    Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D
    Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Marchesi F; Basso G; Rahal D; Delconte G; Catalano M; Cappello P; Roncalli M; Zerbi A; Montorsi M; Novelli F; Mantovani A; Allavena P; Malesci A; Laghi L
    Br J Cancer; 2013 Oct; 109(9):2424-33. PubMed ID: 24084767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer.
    Wang Q; Li M; Gan Y; Jiang S; Qiao J; Zhang W; Fan Y; Shen Y; Song Y; Meng Z; Yao M; Gu J; Zhang Z; Tu H
    Theranostics; 2020; 10(5):2141-2157. PubMed ID: 32089737
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma.
    Li H; Wang P; Deng Y; Zeng M; Tang Y; Zhu WH; Cheng Y
    Biomaterials; 2017 Sep; 139():30-38. PubMed ID: 28582716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ.
    Liu Y; Deguchi Y; Wei D; Liu F; Moussalli MJ; Deguchi E; Li D; Wang H; Valentin LA; Colby JK; Wang J; Zheng X; Ying H; Gagea M; Ji B; Shi J; Yao JC; Zuo X; Shureiqi I
    Nat Commun; 2022 May; 13(1):2665. PubMed ID: 35562376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.
    Nishikawa Y; Kodama Y; Shiokawa M; Matsumori T; Marui S; Kuriyama K; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Sakuma Y; Ota Y; Maruno T; Uza N; Uesugi M; Kageyama R; Chiba T; Seno H
    Oncogene; 2019 May; 38(22):4283-4296. PubMed ID: 30705405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia.
    Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS
    APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
    Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene.
    Liang C; Wang Z; Wu L; Wang C; Yu BH; Yao XZ; Wang XL; Li YY
    Tumour Biol; 2015 Sep; 36(10):7557-68. PubMed ID: 25916208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms.
    Chang X; Yu C; Li J; Yu S; Chen J
    Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of cathepsin E in pancreas: a possible tumor marker for pancreas, a preliminary report.
    Azuma T; Hirai M; Ito S; Yamamoto K; Taggart RT; Matsuba T; Yasukawa K; Uno K; Hayakumo T; Nakajima M
    Int J Cancer; 1996 Aug; 67(4):492-7. PubMed ID: 8759606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
    Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.